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Abstract
Background: Taiwan is endemic for pyogenic liver abscess (PLA). Septic ocular or central nervous system (CNS)
complications derived from PLA can result in catastrophic disability. We investigated the epidemiology and long-term
prognosis of PLA patients with septic ocular or CNS complications over an 8-year period.
Methodology/Principal Findings: We extracted 21,307 patients with newly diagnosed PLA from a nationwide health
registry in Taiwan between 2000 and 2007. The frequency of and risk factors for PLA with septic ocular or CNS complications
were determined. The 2-year survival of these patients was compared between those with and without septic ocular or CNS
complications. Septic ocular or CNS complications accounted for 2.1% of all PLA patients. Age and the Charlson comorbidity
index were significantly lower in PLA patients with ocular or CNS complications than those without. Diabetes and age ,65
years were independent predictors of septic ocular or CNS complications. The 2-year mortality of patients with septic ocular
or CNS complications was similar to those without complications (24.8% vs. 27.5%, p=0.502). However, among patients
,65 years old and a Charlson index #1, the 2-year mortality was significantly higher in those with than without
complications (18.6% vs. 11.8%, p=0.001).
Conclusions/Significance: Physicians should recognize that catastrophic disability due to ocular or neurological
complications from PLA could lead to a poor long-term prognosis, and should follow-up these patients more closely.
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Introduction
Pyogenic liver abscess (PLA) results from bacterial infection of
the liver parenchyma, with subsequent infiltration by inflamma-
tory cells and formation of pus. PLA is associated with significant
morbidity, mortality, and health-care costs [1,2]. The disease is
rare in Western countries, for example, the reported annual
incidence rate was 2.3 per 100,000 population in Canada [1] 1.0
per 100,000 population in Denmark [3], and 3.6 per 100,000
population in the United States [2]. In Taiwan, however, the
annual incidence of PLA has increased steadily from 11.2 per
100,000 population in 1996 to 17.6 per 100,000 population in
2004 [4]. Reported case-fatality rates of PLA from population-
based studies in Western countries are substantial, ranging from
5.6 to 19% [1–3]. According to a previous population-based study,
the overall mortality rate of PLA in Taiwan was 10.9% [4].
Escherichia coli is the most common causative pathogen of PLA in
most countries [5]. However, in the past three decades, Klebsiella
pneumoniae has emerged as the single leading cause of PLA in East
Asian countries, especially in Taiwan [6–13]. A distinct syndrome
of community-acquired pyogenic liver abscess, which is compli-
cated by metastatic endophthalmitis or central nervous system
(CNS) infections, has been reported since 1986, especially in
patients with diabetes [6,11,14–19]. Despite aggressive therapy,
the outcomes of these patients frequently involve catastrophic
disability.
A previous study conducted in Taiwan has suggested that
metastatic infection predicted mortality [17]. However, another
study from a different institute in Taiwan demonstrated a low
mortality rate of PLA, even in patients with septic ocular or CNS
complications, and suggested that the main concern was no longer
mortality, but catastrophic disability due to irreversible ocular or
neurological complications [11]. Although Taiwan is endemic for
PLA [4], population-based studies evaluating the epidemiology
and the long-term outcomes of PLA with septic ocular or CNS
complications have never been reported.
In the present study, we used a nationwide population-based
database to investigate the frequency of, risk factors for, and long-
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over an 8-year period in Taiwan.
Materials and Methods
Database
This study was based on data from the National Health Insurance
(NHI) Research Database released by the National Health Research
Institute. Taiwan began its National Health Insurance program in
1995tofinancehealth careforallof its residents.Thereare currently
more than 25 million enrollees in the program, representing
approximately 99% of Taiwan’s entire population. The database
includes comprehensive information on insured subjects, such as
demographic data, dates of clinical visits, diagnostic codes, details of
prescriptions, and expenditure amounts. International Classification
ofDiseases,Ninth Revisioncodeswereused to definediseasesduring
the study period. Laboratory data and microbiological data are not
included. The highly trustworthy National Health Insurance
Research Database has been used in the research of PLA published
in peer-reviewed journals [4,20]. The dataset used in this study
consists of de-identified secondary data released to the public for
research purposes. This study was approved by the institutional
review board of Taipei Veterans General Hospital. Since the
identification numbers and personal information of all individuals
were not included in the above secondary files to protect the privacy
of the individuals, the review board approved that written consents
from patients were not required.
Study Population
In this retrospective cohort study, we identified 24,897 patients
who had been hospitalized due to a diagnosis of liver abscess (ICD-9-
CM diagnosis code 572.0) between January 1, 2000 to December 31,
2007. Amebic liver abscess (ICD-9-CMdiagnosis code 006.3) was not
included in this study because of its distinct features and etiologies.
Patients with a past history of liver abscess prior to January 1, 2000
(n=510), under the age of 18 years (n=222), with underlying
hepatobiliary malignancies or hepatobiliary malignancies diagnosed
within 60 days (ICD-9-CM 155–156.9) (n=2868) were excluded
[20]. The final sample included 21,297 patients. The underlying
diseases and operative procedures, such as liver resection and
drainage, were also collected for analysis. Comorbidities were
recorded and used to obtain the Charlson comorbidity index [21,22].
PLA patients with septic ocular complications were defined as
PLA patients with purulent endophthalmitis (ICD-9-CM diagnosis
code 360.0–360.04) or those receiving a vitrectomy (ICD-9-CM
procedural codes 14.7–14.79) during the same admission. PLA
patients with CNS complications were defined as PLA patients
with meningitis (320–320.9 and 322.9) or a brain abscess (324–
324.9 and 326) during the same admission.
Statistical Analyses
Comparisons between groups were made using the x2 test for
categorical variables. All comparison tests were two-sided. Risk
factors with P values less than 0.1 were entered into a multivariate
analysis. A P value,0.05 was considered statistically significant.
Survival curves were computed by the Kaplan–Meier method and
were compared with a log-rank test. All statistical analyses were
performed using SPSS statistical software version 17.0 for
Windows (SPSS, Inc., Chicago, Illinois).
Results
During the study period, a total of 21,297 patients with PLA
were enrolled. Patients ranged in age from 18 to 101 years, with a
median age of 61 years. A total of 8,959 (42.1%) patients had
diabetes mellitus, 1,125 (5.3%) had cirrhosis of the liver, 4,484
(21.1%) had cholelithiasis, 1,315 (6.2%) had chronic obstructive
pulmonary disease, 1,348 (6.3%) had chronic kidney disease, and
1,405 (6.6%) had extrahepatic malignancies. Male patients
dominated the study population (13,104/21,307; 61.5%). The
proportions of patients who received abscess drainage and surgical
intervention were 28.5% and 11.6%, respectively. The 60-day
mortality rate was 7.6%.
The number of identified PLA cases increased from 2,277 in
2000 to 2,911 in 2007 (Table 1). Among all of the patients with
PLA, 453 (2.1%) had septic ocular or CNS complications.
Specifically, 294 patients had an endogenous endophthalmitis,
176 patients had meningitis or a brain abscess, and 17 patients had
both ocular and CNS complications. The annual frequency of
PLA with septic ocular or CNS complications was not significantly
different throughout the study period (p=0.068) (Table 1).
The clinical characteristics of PLA patients with and without
septic ocular or CNS complications are presented in Table 2. The
60-day mortality rate was not different between the two groups.
PLA patients with septic ocular or CNS complications were more
likely to be male (66.0% vs. 61.4%; p=0.051) and younger
(56.9613.3 vs. 60.2615.2 years; p,0.001) than patients without
septic ocular or CNS complications. The Charlson comorbidity
index was lower in PLA patients with ocular or CNS complica-
tions that without (1.161.4 vs. 1.561.9; p,0.001). In regards to
underlying diseases, there were no significant differences between
the two groups in underlying liver cirrhosis and cerebrovascular
disease. The prevalence of diabetes was significantly higher among
PLA patients with septic ocular or CNS complications (52.1% vs.
41.8%; p,0.001). Conversely, the prevalence of chronic renal
disease (4.0% vs. 6.4%; p=0.045), chronic obstructive pulmonary
disease (2.9% vs. 6.2%; p=0.003), cholelithiasis (6.6% vs. 21.4%;
p,0.001), congestive heart failure (1.3% vs. 4.9%; p,0.001), and
extrahepatic malignancies (3.8% vs. 6.7%; p=0.016) was
significantly lower among PLA patients with septic ocular or
CNS complications.
A binary logistic regression was used to identify the independent
risk factors for PLA with septic ocular or CNS complications.
Diabetes (odds ratio [OR]=1.46, 95% CI= 1.21–1.76,
P,0.001), and age ,65 years (OR=1.51, 95% CI=1.23–1.86,
p,0.001) were independent predictors of septic ocular or CNS
Table 1. The frequency of PLA cases with septic ocular or
central nervous system complications.
Year
PLA with septic ocular or
central nervous system
complications Total PLA cases %
2000 55 2,277 2.4
2001 46 2,423 1.9
2002 69 2,535 2.7
2003 57 2,604 2.2
2004 67 2,778 2.4
2005 54 2,837 1.9
2006 44 2,932 1.5
2007 61 2,911 2.1
Total 453 21,297 2.1
NOTE. PLA, pyogenic liver abscess.
doi:10.1371/journal.pone.0033978.t001
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(OR= 0.61, 95% CI=0.37–0.99, p = 0.047), cholelithiasis
(OR= 0.29, 95% CI=0.20–0.43, p,0.001), and congestive heart
failure (OR= 0.31, 95% CI=0.14–0.71, p=0.005) were
associated with a lower risk of septic ocular or CNS complications
in PLA patients.
The Kaplan-Meier survival curves of PLA patients with and
without septic ocular or CNS complications are presented in
Figure 1. There was no significant difference in the 2-year
mortality between PLA patients with and without septic ocular or
CNS complications (24.8% vs. 27.5%, p=0.502, by log-rank test).
We further selected PLA patients ,65 years old and a Charlson
comorbidity #1 (i.e. between 0 and 1) for further comparison (249
patients with complications and 9082 without complications), and
the 2-year mortality was significantly higher among PLA patients
with septic ocular or CNS complications than those without
(18.6% vs. 11.8%, p=0.001, by log-rank test) (Figure 2).
Discussion
The present study is a first ever nationwide population-based
study to report on the epidemiology and long-term outcomes of
PLA with septic ocular or CNS complications in Taiwan. The
strengths of the present study are that it is based on a large
nationwide population-based sample, contains data on a wide
variety of demographic characteristics, and has a complete history
of the medical service used by the sampled patients. We found that
2.1% of all PLA cases presented with septic ocular or CNS
complications. It should be noted that the annual frequency of
septic ocular or CNS complications was relatively steady
throughout the study period. Although management of PLA has
improved in Taiwan due to increased physician awareness [4], it is
still likely that complications arise at the time of presentation, and
thereby, are not preventable, regardless of the antibiotic treatment
used [17]. Therefore, it is essential for physicians to maintain high
clinical vigilance for the development of these metastatic infections
through early detection and management of high-risk patients in
the endemic region.
Investigations comparing the clinical features of PLA patients
with and without septic ocular or CNS complications have been
rarely reported [17]. The risk factors for septic metastatic
infections include the virulence factors of K. pneumoniae [11] and
host factors, such as diabetes [18]. The current nationwide
population-based study focused on host factors and demonstrated
that individuals with diabetes and an age ,65 years are
predisposed to metastatic infection via multivariate analysis. The
concept that younger individuals are more susceptible to
metastatic infection has never been reported, in part, due to the
small sample sizes of patients in the literature [11,17,18]. As for
other demographic data, extrahepatic cancer, cholelithiasis, and
congestive heart failure were all associated with a lower risk of
septic ocular or CNS complications. All of these findings suggest
that septic ocular or CNS complications are more likely to develop
in younger and diabetic, but otherwise healthy, patients.
In one previous study, 70% of patients with septic ocular or
CNS complications experienced irreversible catastrophic disabil-
ity, including loss of vision in the affected eye(s), quadriplegia,
paraparesis, or impaired higher cortical function [11]. Poor visual
outcomes, despite aggressive management, were also documented
[16,18,23]. However, the long-term mortality of patients with
septic ocular or CNS complications has not yet been investigated.
The short-term mortality (i.e. 60-day) was slightly higher in PLA
Table 2. Clinical characteristics of PLA patients with and without septic ocular or central nervous system complications.
Characteristics
PLA patients with septic ocular or central
nervous system complications (n=453)
PLA patients without septic ocular or central
nervous system complications (n=20,844) p value
Number % Number %
Gender 0.051
Male 299 66.0 12,805 61.4
Female 154 34.0 8,039 38.6
Age ,0.001
,65 230 70.6 12,015 57.6
$65 133 29.4 8,829 42.4
Underlying diseases
Diabetes mellitus 236 52.1 8,723 41.8 ,0.001
Chronic renal failure 18 4.0 1,330 6.4 0.045
Extrahepatic malignancy 17 3.8 1,388 6.7 0.016
Chronic obstructive pulmonary disease 13 2.9 1,302 6.2 0.003
Liver cirrhosis 20 4.4 1,105 5.3 0.454
Cholelithiasis 30 6.6 4,454 21.4 ,0.001
Congestive heart failure 6 1.3 1,014 4.9 ,0.001
Cerebrovascular disease 39 8.6 2,129 10.2 0.307
Management
Abscess drainage 149 32.9 5,923 28.4 0.039
Surgical intervention 41 9.1 2,422 11.6 0.105
60-day mortality 41 9.1 1,570 7.5 0.241
NOTE. PLA, pyogenic liver abscess.
doi:10.1371/journal.pone.0033978.t002
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statistically significant (9.1% vs. 7.5%; p=0.241). It may be
reasonable to suggest that the infectious process per se was the
dominant cause of short-term mortality. However, irreversible
catastrophic disability from septic ocular or CNS complications
may lead to mortality in a few months to years later. Recognizing
the potential for adverse long-term outcomes is important, as the
findings from previous studies that evaluated only the short-term
mortality likely underestimated the true burden of the illnesses
associated with PLA.
It is well-known that co-morbid illnesses and age have an
important influence on long-term mortality of infectious diseases
[24,25]. The older age and co-morbidities may contribute to the
long-term mortality significantly in PLA patients without septic
ocular or CNS complications. Although PLA patients with
complications were younger and had a lower Charlson cormo-
bidity index than those without complications, the complications
may lead to the similar long-term outcome between the 2 groups.
The long-term mortality following infection may be attributable to
a combination of pre-existing co-morbidities, the nature and
severity of the initial infection, and the direct complications arising
from this acute disease. Given the lower number of co-morbidities
and the slightly higher short-term mortality, the long-term
mortality of PLA patients with septic ocular or CNS complications
may be attributed to irreversible catastrophic disability. To clarify
the poor long-term prognosis of PLA patients with septic ocular or
CNS complications, PLA patients ,65 years old and a Charlson
comorbidity index #1 were selected for further analysis. The
result demonstrated that these patients have a lower 2-year
survival than those without septic ocular or CNS complications.
Thus, physicians should be informed about the distinct
clinical group of PLA patients that are younger and have less
co-morbidities, and simultaneously carry a poor long-term
prognosis.
This study suffers from several limitations. First, the study does
not have microbiological data, however, it is well established that
K. pneumoniae is the major etiological factor of PLA in Taiwan, and
is exclusively responsible for septic ocular or CNS complications
[11]. Second, detailed clinical variables, including clinical
manifestations and laboratory findings, were not available.
Consequently, we were not able to directly assess the relationship
between the severity of disease and long-term mortality. Lastly, we
did not include quality of life measurement, which are important
markers of long-term outcome following PLA.
In conclusion, this study provides a clear picture of with respect
to the disease burden of PLA with septic ocular and CNS
complications in Taiwan. Our findings indicate that septic ocular
or CNS complications accounts for 2.1% of PLA patients in
Taiwan. Septic ocular or CNS complications are more likely to
develop in younger and diabetic, but otherwise healthy, patients.
Physicians should recognize that catastrophic disability due to
ocular or neurological complications from PLA could lead to a
poorer long-term prognosis, and thereby, follow up these patients
more closely. A comprehensive and collaborative management of
PLA via the combined efforts of multiple medical subspecialties is
necessary to tackle this problem in the future.
Figure 1. A comparison of 2-year Kaplan–Meier survival curves of PLA patients with and without septic ocular or CNS complications
(p=0.502, by log-rank test).
doi:10.1371/journal.pone.0033978.g001
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